Sweden Country Drug Report 2017

Quality assurance

The ANDT emphasises the need for a knowledge base and evidence-based interventions to achieve high-quality drug-related treatment and prevention activities. Several actors, including both independent national agencies and government agencies, work in the field of quality assurance and best practice by evaluating methods used and by providing guidance to treatment providers through guidelines and knowledge provision.

The Swedish Agency for Health Technology Assessment and Assessment of Social Services is an independent national authority tasked by the government with the assessment of healthcare interventions from a broad perspective, covering medical, economic, ethical and social issues. In 2015, it published an evaluation of the scientific evidence for prevention initiatives for the misuse of substances. The National Board of Health and Welfare, a government agency under the Ministry of Health and Social Affairs, publishes guidelines on the treatment of substance use and dependence. An updated version of these guidelines was published in 2015.

In Sweden, there is no general accreditation system in place for drug-related interventions, but service providers or those who implement different projects often have their own accreditation systems to assure the quality and effectiveness of the interventions they provide.

In 2015, to support the health promotion and prevention efforts among PWID implemented at the regional level, the Public Health Agency launched guidelines on the prevention of infectious diseases, based on the EMCDDA and ECDC joint guideline ‘Prevention and control of infectious diseases among people who inject drugs’ (2011).

The National Board of Health and Welfare, a government agency under the Ministry of Health and Social Affairs, publishes guidelines on the treatment of substance use and dependence. An updated version of these guidelines was published in 2015


Sweden main page